News

EBUS Equals Mediastinoscopy for NSCLC Staging


 

FROM THE AMERICAN ASSOCIATION FOR THORACIC SURGERY ANNUAL MEETING

No complications occurred after EBUS-TBNA, but there were four minor complications following subsequent mediastinoscopy: Two patients had a hematoma, one had a recurrent nerve injury, and one had a wound infection.

"It was a very clean study, showing that in the hands of a trained surgeon in our setting, EBUS-TBNA works very well. We clearly showed that the diagnostic yield is similar, and that patients who require mediastinoscopy as part of their staging can undergo EBUS-TBNA as their initial modality. Depending on what you find, you want to also do mediastinoscopy," he added.

"I’m convinced that [Dr. Yasufuku has] demonstrated equivalent ability to stage the mediastinum with EBUS-TBNA and with mediastinoscopy," commented Dr. Joel D. Cooper, professor of surgery and chief of thoracic surgery at the University of Pennsylvania in Philadelphia.

The study was supported by Olympus Medical Systems, a company that markets an EBUS-TBNA system. Dr. Yasufuku said that he has received research support from Olympus. Dr. Cooper said that he had no relevant disclosures.

Pages

Recommended Reading

HPV-Related Oral Cancer Incidence Spikes Sharply
MDedge Hematology and Oncology
Exemestane Prevents 65% of Invasive Breast Cancers in Postmenopausal Women
MDedge Hematology and Oncology
Crizotinib Continues to Produce High Response in ALK+ NSCLC
MDedge Hematology and Oncology
Bevacizumab Shows Promise for High-Risk Ovarian Cancer
MDedge Hematology and Oncology
Bevacizumab Halves Progression Risk in Recurrent Ovarian Cancer
MDedge Hematology and Oncology
Survey Highlights Survivor Care Issues
MDedge Hematology and Oncology
BRAF Inhibitor Cuts Death Risk in Advanced Melanoma
MDedge Hematology and Oncology
Ipilimumab Added to Dacarbazine Prolongs Survival for Metastatic Melanoma
MDedge Hematology and Oncology
Longer Imatinib Therapy Improves Outcomes For High-Risk GIST
MDedge Hematology and Oncology
Pemetrexed Continuation Maintenance Slows NSCLC Progression
MDedge Hematology and Oncology